Terms: = Lymphoma AND BTG1, P62324, 694, ENSG00000133639 AND Diagnosis
26 results:
1. Prevalence and predictors for fertility-related distress among 1010 young adults 1.5 years following cancer diagnosis - results from the population-based Fex-Can Cohort study.
Rodriguez-Wallberg KA; Ahlgren J; Smedby KE; Gorman JR; Hellman K; Henriksson R; Ståhl O; Wettergren L; Lampic C
Acta Oncol; 2023 Dec; 62(12):1599-1606. PubMed ID: 37909865
[TBL] [Abstract] [Full Text] [Related]
2. Development and validation of a survival nomogram in patients with primary testicular diffuse large B-cell lymphoma.
Zhi Y; Bao S; Mao J; Chai G; Liu C; Zhu J
J Int Med Res; 2023 Sep; 51(9):3000605231197052. PubMed ID: 37676929
[TBL] [Abstract] [Full Text] [Related]
3. High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy.
Visentini M; Pica A; D'Ippolito G; Sculco E; La Gualana F; Gragnani L; Miglionico M; Mazzaro C; Fiorilli M; Basili S; Martelli M; Di Rocco A; Casato M; Gentile G; Pulsoni A
Ann Hematol; 2023 Dec; 102(12):3457-3463. PubMed ID: 37650886
[TBL] [Abstract] [Full Text] [Related]
4. Survival differences between patients with de novo and relapsed/progressed advanced non-small cell lung cancer without epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangements.
Oh BC; Cho AR; Nam JH; Yang SY; Kim MJ; Kwon SH; Lee EK
BMC Cancer; 2023 May; 23(1):482. PubMed ID: 37248452
[TBL] [Abstract] [Full Text] [Related]
5. Coexpression of PD-L1/PD-1 with CXCR3/CD36 and IL-19 Increase in Extranodal lymphoma.
Saber MM
J Immunol Res; 2023; 2023():4556586. PubMed ID: 36726488
[TBL] [Abstract] [Full Text] [Related]
6. Prevalence and risk factors for sexual dysfunction in young women following a cancer diagnosis - a population-based study.
Wettergren L; Eriksson LE; Bergström C; Hedman C; Ahlgren J; Smedby KE; Hellman K; Henriksson R; Lampic C
Acta Oncol; 2022 Oct; 61(10):1165-1172. PubMed ID: 36176069
[TBL] [Abstract] [Full Text] [Related]
7. The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends.
Huang J; Chan SC; Lok V; Zhang L; Lucero-Prisno DE; Xu W; Zheng ZJ; Elcarte E; Withers M; Wong MCS;
Lancet Haematol; 2022 Sep; 9(9):e670-e677. PubMed ID: 35843248
[TBL] [Abstract] [Full Text] [Related]
8. Oncogenic Mutations and Tumor Microenvironment Alterations of Older Patients With Diffuse Large B-Cell lymphoma.
Zhu Y; Fu D; Shi Q; Shi Z; Dong L; Yi H; Liu Z; Feng Y; Liu Q; Fang H; Cheng S; Wang L; Tian Q; Xu P; Zhao W
Front Immunol; 2022; 13():842439. PubMed ID: 35401516
[TBL] [Abstract] [Full Text] [Related]
9. The outcome of watchful waiting in patients with previously treated follicular lymphoma.
Fujino T; Maruyama D; Maeshima AM; Saito Y; Ida H; Hosoba R; Yuda S; Makita S; Fukuhara S; Munakata W; Suzuki T; Kuroda J; Izutsu K
Cancer Med; 2022 May; 11(10):2106-2116. PubMed ID: 35129305
[TBL] [Abstract] [Full Text] [Related]
10. Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic Leukemia with Prognosis.
Hosein Pour Feizi A; Zeinali S; Toporski J; Sheervalilou R; Mehranfar S
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3493-3500. PubMed ID: 33369444
[TBL] [Abstract] [Full Text] [Related]
11. [CD20 is not a poor prognostic factor for childhood B-lineage acute lymphoblastic leukemia with high white blood cell count].
Zhang LY; Chen XJ; Wang SC; Guo Y; Yang WY; Chen YM; Zhang L; Zou Y; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Jul; 22(7):728-733. PubMed ID: 32669169
[TBL] [Abstract] [Full Text] [Related]
12. MLPA and DNA index improve the molecular diagnosis of childhood B-cell acute lymphoblastic leukemia.
Yu CH; Lin TK; Jou ST; Lin CY; Lin KH; Lu MY; Chen SH; Cheng CN; Wu KH; Wang SC; Chang HH; Li MJ; Ni YL; Su YN; Lin DT; Chen HY; Harrison CJ; Hung CC; Lin SW; Yang YL
Sci Rep; 2020 Jul; 10(1):11501. PubMed ID: 32661308
[TBL] [Abstract] [Full Text] [Related]
13. Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913.
Chiaretti S; Messina M; Della Starza I; Piciocchi A; Cafforio L; Cavalli M; Taherinasab A; Ansuinelli M; Elia L; Albertini Petroni G; La Starza R; Canichella M; Lauretti A; Puzzolo MC; Pierini V; Santoro A; Spinelli O; Apicella V; Capria S; Di Raimondo F; De Fabritiis P; Papayannidis C; Candoni A; Cairoli R; Cerrano M; Fracchiolla N; Mattei D; Cattaneo C; Vitale A; Crea E; Fazi P; Mecucci C; Rambaldi A; Guarini A; Bassan R; Foà R
Haematologica; 2021 Jun; 106(6):1559-1568. PubMed ID: 32467145
[TBL] [Abstract] [Full Text] [Related]
14. Non-melanoma skin cancer as a clinical marker for internal malignancies: a nationwide population-based cohort study.
Yun SJ; Bae JM; Kim H; Park BC; Kim JS; Seo SH; Ahn HH; Lee DY; Kim YC; Park HJ; Chung KY
J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):746-753. PubMed ID: 31494979
[TBL] [Abstract] [Full Text] [Related]
15. Chromosomal microarray analysis is superior in identifying cryptic aberrations in patients with acute lymphoblastic leukemia at diagnosis/relapse as a single assay.
Chen C; Heng EYH; Lim AST; Lau LC; Lim TH; Wong GC; Tien SL
Int J Lab Hematol; 2019 Aug; 41(4):561-571. PubMed ID: 31112375
[TBL] [Abstract] [Full Text] [Related]
16. Impact of comorbidity on survival in peripheral T-cell lymphomas: A Swedish lymphoma Registry study.
Ellin F; Jerkeman M; Törnqvist J; Brudin L; Relander T
Hematol Oncol; 2018 Feb; 36(1):159-165. PubMed ID: 28474339
[TBL] [Abstract] [Full Text] [Related]
17. Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia.
Irving JA; Enshaei A; Parker CA; Sutton R; Kuiper RP; Erhorn A; Minto L; Venn NC; Law T; Yu J; Schwab C; Davies R; Matheson E; Davies A; Sonneveld E; den Boer ML; Love SB; Harrison CJ; Hoogerbrugge PM; Revesz T; Saha V; Moorman AV
Blood; 2016 Aug; 128(7):911-22. PubMed ID: 27229005
[TBL] [Abstract] [Full Text] [Related]
18. Effective VCR/DEX pulse maintenance therapy in the KYCCSG ALL-02 protocol for pediatric acute lymphoblastic leukemia.
Okamoto Y; Koga Y; Inagaki J; Ozono S; Ueda K; Shimoura M; Itonaga N; Shinkoda Y; Moritake H; Nomura Y; Nakayama H; Hotta N; Hidaka Y; Shimonodan H; Suga N; Tanabe T; Nakashima K; Fukano R; Kawano Y
Int J Hematol; 2016 Feb; 103(2):202-9. PubMed ID: 26586463
[TBL] [Abstract] [Full Text] [Related]
19. Clinical, virologic, and immunologic outcomes in lymphoma survivors and in cancer-free, HIV-1-infected patients: a matched cohort study.
Spagnuolo V; Travi G; Galli L; Cossarini F; Guffanti M; Gianotti N; Salpietro S; Lazzarin A; Castagna A
Cancer; 2013 Aug; 119(15):2710-9. PubMed ID: 23625649
[TBL] [Abstract] [Full Text] [Related]
20. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia.
te Winkel ML; Pieters R; Hop WC; de Groot-Kruseman HA; Lequin MH; van der Sluis IM; Bökkerink JP; Leeuw JA; Bruin MC; Egeler RM; Veerman AJ; van den Heuvel-Eibrink MM
J Clin Oncol; 2011 Nov; 29(31):4143-50. PubMed ID: 21947829
[TBL] [Abstract] [Full Text] [Related]
[Next]